Skip to content

Propofol versus Midazolam for Procedural Sedation of Anterior Shoulder Dislocation

Propofol versus Midazolam for Procedural Sedation of Anterior Shoulder Dislocation in Emergency Department; A Randomized Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201501236238N2
Enrollment
48
Registered
2015-02-23
Start date
2011-03-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dislocation of shoulder joint. Contusion of shoulder and upper arm

Interventions

Intervention 1: Fentanyl injection was initially administered at a dose of 1 µg/kg. Then, a bolus of propofol titrated (slow IV during 30 seconds) until the spontaneous eyelid close. Intervention 2: F
Treatment - Drugs
Fentanyl injection was initially administered at a dose of 1 µg/kg. Then, a bolus of propofol titrated (slow IV during 30 seconds) until the spontaneous eyelid close.
Fentanyl injection was initially administered at a dose of 1 µg/kg. Then,intravenous midazolam 2mg/kg injected slowly during 30 seconds and titrated to spontaneous eyelid closed

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The inclusion criteria include anterior dislocation of the shoulder and over 18 years of age. The exclusion criteria include hypersensitivity to midazolam, propofol, or fentanyl; other injury (fracture around shoulder or other limb); intake of food or fluid during last 4 hours; presence of airway difficulty; sensory problems; motor problems, vascular problems, and consumption of alcohol or other recreational drug during past 6 hours.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Success of reduction. Timepoint: after each reducing process. Method of measurement: Physical examination and X-ray.

Secondary

MeasureTime frame
Complication. Timepoint: after reduction and each subsequesnt visit. Method of measurement: History, physical examination and X-ray.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Hamid Reza Hatamabadi

Shahid Beheshti University of Medical Sciences

hhatamabadi@sbmu.ac.ir+98 21 7755 8081

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026